How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

Our tool calculates your customized insurance rates. We'll show you the average cost of our recommendation, or the cost of a policy you customize yourself. First, let’s see what the minimum coverage ...

Abstract: Grounded in Bayesian filtering (BF), random matrix-based extended object tracking (EOT) offers an efficient framework for the joint estimation of a target’s kinematic state and extension.